Postdoctoral research Fellow of Beth Israel Deaconess Medical Center – Harvard Medical School, United States
Marti Ortega Ribera is a dedicated Postdoctoral Research Fellow with a profound commitment to biomedical research, particularly in liver diseases. His journey in the field began during a summer internship in July 2013 at the IDIBAPS Research Institute, where he worked on understanding the effects of ischemia reperfusion injury in liver sinusoidal endothelial cells. This early exposure fueled his passion for liver biology, leading him to pursue extensive research in liver vascular biology, hepatic hemodynamics, aging, and cirrhosis throughout his academic and professional career. Ortega Ribera’s research has significantly advanced the understanding of liver diseases, particularly in the context of cholestatic liver disease and alcohol-induced liver injury.
Professional profile
Education📚
Marti Ortega Ribera received his Bachelor of Science in Biology from the University of Barcelona, Spain, in July 2014. He continued at the same institution, completing a Master of Science in Translational Medicine in July 2015. Ortega Ribera then pursued a Ph.D. in Medicine and Translational Research, which he completed in July 2021 at the University of Barcelona and CNM-CSIC, Universitat Autònoma de Barcelona, Spain. His doctoral research focused on liver biology, particularly the mechanobiology of chronic liver disease. In November 2021, he began a postdoctoral fellowship at the Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA, where he currently researches the role of innate immunity and inflammation in liver diseases.
Professional Experience🏛️
- Holds a position as a Postdoctoral Research Fellow at a prestigious institution (BIDMC, Harvard Medical School).
- Active involvement in various professional associations related to liver research, including the American Association for the Study of the Liver.
Research Interest🌐
Marti Ortega Ribera’s research interests are centered around the intricate mechanisms underlying liver diseases, with a specific focus on liver vascular biology, hepatic hemodynamics, and the role of aging and cirrhosis in liver function. His work delves into the mechanobiology of chronic liver diseases, exploring how mechanical forces and cellular interactions contribute to disease progression. Ortega Ribera is particularly interested in the effects of ischemia reperfusion injury on liver sinusoidal endothelial cells and the implications for liver disease progression.
Awards and Honors🏆
- Multiple awards for posters and abstracts at various research conferences, indicating recognition by peers for the quality of research.
- Winner of prestigious awards such as the IMFAHE’s Nodal Award-Shark Tank 2024 and the Arias Vallejo Award.
Research skill🔬
Marti Ortega Ribera’s research interests are centered around the intricate mechanisms underlying liver diseases, with a specific focus on liver vascular biology, hepatic hemodynamics, and the role of aging and cirrhosis in liver function. His work delves into the mechanobiology of chronic liver diseases, exploring how mechanical forces and cellular interactions contribute to disease progression. Ortega Ribera is particularly interested in the effects of ischemia reperfusion injury on liver sinusoidal endothelial cells and the implications for liver disease progression.
Achievements🏅
- 2024: IMFAHE’s Nodal Award-Shark Tank.
- 2023: Poster Award at the Annual Research Retreat from Beth Israel Deaconess Medical Center.
- 2022: Poster Award at the 21st Conference from the International Society for the Hepatic Sinusoid Research.
- 2022: Arias Vallejo Award for best basic abstract from the Spanish Gastroenterology Foundation.
- 2020: Basic Research Abstract Award at the 29th Conference from the Catalan Society of Gastroenterology.
Publication📜
- 📚 Review: Learning about liver regeneration from liver-on-a-chip
Current Opinion in Biomedical Engineering, 2024, 30, 100533
Citations: 0
- 📚 Article: Alcohol-Associated Liver Disease Outcomes: Critical Mechanisms of Liver Injury Progression
Biomolecules, 2024, 14(4), 404
Citations: 0
- 📚 Article: Bile acid-induced IRF3 phosphorylation mediates cell death, inflammatory responses, and fibrosis in cholestasis-induced liver and kidney injury via regulation of ZBP1
Hepatology, 2024, 79(4), pp. 752–767
Citations: 9
- 📚 Letter: Reply to: Exercise greater caution in bile acid research
Hepatology, 2024, 10.1097/HEP.0000000000001017
Citations: 0
- 📚 Book Chapter: Sinusoidal cell interactions—From soluble factors to exosomes
In Sinusoidal Cells in Liver Diseases: Role in their Pathophysiology, Diagnosis, and Treatment, 2024, pp. 23–52
Citations: 0
- 📚 Article: G-CSF increases calprotectin expression, liver damage and neuroinflammation in a murine model of alcohol-induced ACLF
Frontiers in Cell and Developmental Biology, 2024, 12, 1347395
Citations: 1
- 📚 Article: Altered anti-viral immune responses in monocytes in overweight heavy drinkers
iScience, 2023, 26(7), 107133
Citations: 0
- 📚 Article: Increased sinusoidal pressure impairs liver endothelial mechanosensing, uncovering novel biomarkers of portal hypertension
JHEP Reports, 2023, 5(6), 100722
Citations: 12
- 📚 Review: In Vitro Models for the Study of Liver Biology and Diseases: Advances and Limitations
Cellular and Molecular Gastroenterology and Hepatology, 2023, 15(3), pp. 559–571
Citations: 17
- 📚 Article: Methoxyeugenol deactivates hepatic stellate cells and attenuates liver fibrosis and inflammation through a PPAR-ɣ and NF-kB mechanism
Journal of Ethnopharmacology, 2021, 280, 114433
Citations: 44
